Free Trial

267,500 Shares in Blend Labs, Inc. (NYSE:BLND) Bought by Washington Harbour Partners LP

Blend Labs logo with Computer and Technology background

Washington Harbour Partners LP purchased a new position in Blend Labs, Inc. (NYSE:BLND - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 267,500 shares of the company's stock, valued at approximately $1,126,000. Blend Labs accounts for about 2.1% of Washington Harbour Partners LP's investment portfolio, making the stock its 21st biggest position. Washington Harbour Partners LP owned approximately 0.10% of Blend Labs at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of BLND. JPL Wealth Management LLC purchased a new position in Blend Labs in the 4th quarter valued at approximately $42,000. Balyasny Asset Management L.P. purchased a new position in Blend Labs in the 4th quarter valued at approximately $46,000. Olympiad Research LP purchased a new position in Blend Labs in the 4th quarter valued at approximately $47,000. Trellis Wealth Advisors LLC purchased a new position in Blend Labs in the 4th quarter valued at approximately $57,000. Finally, BBR Partners LLC purchased a new position in Blend Labs in the 4th quarter valued at approximately $60,000. 52.56% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts recently weighed in on the stock. Keefe, Bruyette & Woods lifted their price objective on shares of Blend Labs from $3.50 to $4.00 and gave the company a "market perform" rating in a research note on Monday, May 19th. The Goldman Sachs Group reduced their price objective on shares of Blend Labs from $5.60 to $4.80 and set a "buy" rating for the company in a research note on Monday, May 12th. Wells Fargo & Company reduced their price objective on shares of Blend Labs from $6.00 to $5.00 and set an "overweight" rating for the company in a research note on Tuesday, April 22nd. Canaccord Genuity Group restated a "buy" rating and set a $5.25 price target on shares of Blend Labs in a research report on Monday, May 12th. Finally, UBS Group reduced their price target on shares of Blend Labs from $4.00 to $3.50 and set a "neutral" rating for the company in a research report on Friday, February 28th. Two research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Blend Labs presently has a consensus rating of "Moderate Buy" and an average price target of $4.90.

Get Our Latest Research Report on Blend Labs

Blend Labs Stock Down 1.0%

NYSE:BLND traded down $0.04 during midday trading on Friday, hitting $3.50. The company had a trading volume of 2,773,409 shares, compared to its average volume of 3,011,674. Blend Labs, Inc. has a 52-week low of $2.08 and a 52-week high of $5.53. The stock's fifty day moving average price is $3.37 and its 200-day moving average price is $3.88. The company has a market capitalization of $907.52 million, a PE ratio of -10.28 and a beta of 1.29.

About Blend Labs

(Free Report)

Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.

See Also

Institutional Ownership by Quarter for Blend Labs (NYSE:BLND)

Should You Invest $1,000 in Blend Labs Right Now?

Before you consider Blend Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Blend Labs wasn't on the list.

While Blend Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir at All-Time Highs: Take Profits or Hold the Line?
3 Tech Stocks Insiders Are Buying: Speculative Plays for June
3 Defense Stocks Set to Crush the S&P This Summer

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines